| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:478-484.)
© 2008 American Heart Association, Inc.
Cardiovascular Surgery |
From the Departments of Anesthesia (K.K., D.N.W., W.S.B.) and Health Policy, Management, and Evaluation (K.K., D.N.W.), University Health Network, University of Toronto, Toronto, Ontario, Canada.
Correspondence to Keyvan Karkouti, MD, University Health Network, Toronto General Hospital, Department of Anesthesia, EN 3–402, 200 Elizabeth St, Toronto, Ontario, Canada, M5G 2C4. E-mail keyvan.karkouti{at}uhn.on.ca
Received May 29, 2007; accepted November 20, 2007.
Background— Preoperative anemia is an important risk factor for perioperative red blood cell transfusions, which are associated with postoperative morbidity and mortality. Whether preoperative anemia also is an independent risk factor for adverse outcomes after cardiac surgery, however, has not been fully elucidated.
Methods and Results— In this multicenter cohort study, data were collected on 3500 consecutive patients who underwent cardiac surgery during 2004 at 7 academic hospitals. The prevalence of preoperative anemia, defined as hemoglobin <12.5 g/dL, and its unadjusted and adjusted relationships with the composite outcome of in-hospital death, stroke, or acute kidney injury were obtained. The overall prevalence of preoperative anemia was 26%, with values ranging from 22% to 30% at the participating hospitals. After the exclusion of patients who had severe preoperative anemia (hemoglobin <9.5 g/dL) or preoperative kidney failure and those who underwent emergency surgery, the composite outcome was observed in 7.5% of patients (247 of 3286). The unadjusted odds ratio for the composite outcome in anemic versus nonanemic patients was 3.6 (95% confidence interval, 2.7 to 4.7). The risk-adjusted odds ratios, obtained by multivariable logistic regression and propensity-score matching to control for important confounders (including comorbidities, institution, surgical factors, and blood transfusion), were 2.0 (95% confidence interval, 1.4 to 2.8) and 1.8 (95% confidence interval, 1.2 to 2.7), respectively.
Conclusions— Preoperative anemia is independently associated with adverse outcomes after cardiac surgery. Future studies should determine whether therapies aimed at treating preoperative anemia would improve the outcomes of patients undergoing cardiac surgery.
Related Article:
This article has been cited by other articles:
![]() |
D. Goei, W.-J. Flu, S. E. Hoeks, W. Galal, M. Dunkelgrun, E. Boersma, R. Kuijper, J.-P. van Kuijk, T. A. Winkel, O. Schouten, et al. The Interrelationship Between Preoperative Anemia and N-Terminal Pro-B-Type Natriuretic Peptide: The Effect on Predicting Postoperative Cardiac Outcome in Vascular Surgery Patients Anesth. Analg., November 1, 2009; 109(5): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Bassand, R. Afzal, J. Eikelboom, L. Wallentin, R. Peters, A. Budaj, K. A.A. Fox, C. D. Joyner, S. Chrolavicius, C. B. Granger, et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Eur. Heart J., October 12, 2009; (2009) ehp401v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. De Santo, G. Romano, A. Della Corte, V. de Simone, F. Grimaldi, M. Cotrufo, and M. de Feo Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.M. van Straten, M. A. Soliman Hamad, A. J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting: A Comparison With the Matched General Population Circulation, July 14, 2009; 120(2): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403. [Full Text] [PDF] |
||||
![]() |
M. A. Hlatky and P. A. Heidenreich The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1459 - 1466. [Full Text] [PDF] |
||||
![]() |
K. Karkouti, D. N. Wijeysundera, T. M. Yau, J. L. Callum, D. C. Cheng, M. Crowther, J.-Y. Dupuis, S. E. Fremes, B. Kent, C. Laflamme, et al. Acute Kidney Injury After Cardiac Surgery: Focus on Modifiable Risk Factors Circulation, February 3, 2009; 119(4): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. T. Hare, A. K. Y. Tsui, A. T. McLaren, T. E. Ragoonanan, J. Yu, and C. D. Mazer Anemia and Cerebral Outcomes: Many Questions, Fewer Answers Anesth. Analg., October 1, 2008; 107(4): 1356 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morrice, B. G. Loef, R. Henning, G. Navis, A. Rankin, W. van Oeveren, T. Ebels, and A. Epema Renal oxygen delivery during cardiopulmonary bypass Br. J. Anaesth., September 1, 2008; 101(3): 430 - 431. [Full Text] [PDF] |
||||
![]() |
K. Karkouti, W. S. Beattie, R. Arellano, T. Aye, J. S. Bussieres, J. L. Callum, D. Cheng, L. Heinrich, B. Kent, T. W.R. Lee, et al. Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery Circulation, July 22, 2008; 118(4): 331 - 338. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |